Iberdomide Combined With Low-dose Cyclophosphamide and Dexamethasone
Clinical trial NCT04392037 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04392037
- Sponsor
- Amsterdam UMC, location VUmc
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-17
- Primary completion
- 2027-12-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.